@ARTICLE{
author={Afzali Anita,Panes Julian,Sands Bruce E,Rubin David T,Panaccione Remo,Terry Natalie A,Salese Leonardo,Van Rampelbergh Rian,Yang Zijiang,Frustaci Mary Ellen,Tarabar Dino K,Chen Minhu,Mihaly Emese,Wolf Douglas,D'Haens Geert R},
year={2024},
title={Efficacy of Guselkumab in Moderately to Severely Active Crohn's Disease According to Induction Clinical Response Status: Week 48 Results from the GALAXI 2 & 3 Phase 3 Trials},
journal={AMERICAN JOURNAL OF GASTROENTEROLOGY},
volume={119},
number={10S},
pages={S1024-S1025},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Feagan Brian G,Vermeire Severine,Sandborn William J,Reinisch Walter,Panes Julian,Tarabar Dino K,Su Chinyu,Niezychowski Wojciech,Zhang Haiying,Friedman Gary S,Woodworth Deborah A,Sands Bruce E},
year={2017},
title={Tofacitinib for Maintenance Therapy in Patients With Active Ulcerative Colitis in the Phase 3 OCTAVE Sustain Trial: Results by Local and Central Endoscopic Assessments},
journal={AMERICAN JOURNAL OF GASTROENTEROLOGY},
volume={112},
number={},
pages={S329-S329},
document_type={Meeting Abstract},
} 

